US-based medical device security and asset management company Medigate has secured $30m as part of its Series B round led by new investor Partech.
The round, which takes Medigate’s total funding to $50m, was joined by its existing investors YL Ventures, US Venture Partners (USVP) and Blumberg Capital, along with new investor Maor Investments.
Medigate said it will use the investment to fulfil its vision of becoming healthcare’s security and clinical analytics company.
The healthcare organisations are currently scaling up their digital strategies to include technology such as wearable devices designed for patient monitoring and mobile devices used for telehealth.
